R0016041 |
Benzeneacetic acid, α-[(4-methylbenzoyl)amino]- |
Benzeneacetic acid, α-[(4-methylbenzoyl)amino]-
|
R0016042 |
Benzeneacetic acid, α-[(3-chlorobenzoyl)amino]- |
Benzeneacetic acid, α-[(3-chlorobenzoyl)amino]-
|
R0016043 |
顺-3-碘丙烯酸乙酯 |
Ethyl cis-3-Iodoacrylate (stabilized with Copper chip)
|
R0016044 |
3-叔丁硫基-2-氨基吡啶 |
3-(tert-Butylthio)pyridin-2-amine
|
R0016045 |
反式-3-(苄氧基)环丁醇 |
trans-3-(Benzyloxy)cyclobutanol
|
R0016046 |
cis-cyclobutane-1,3-diol |
cis-cyclobutane-1,3-diol
|
R0016047 |
6-氨基螺[3.3]庚烷-2-羧酸甲酯盐酸盐 |
Methyl 6-aminospiro[3.3]heptane-2-carboxylate hydrochloride
|
R0016048 |
1-(6,7-二氢-5H-吡咯[2,1-C][1,2,4]三唑-3-甲胺 |
6,7-Dihydro-5H-pyrrolo[2,1-c]-1,2,4-triazole-3-methanamine
|
R0016049 |
3-methylsulfonylbicyclo[1.1.1]pentan-1-amine |
3-methylsulfonylbicyclo[1.1.1]pentan-1-amine
|
R0016050 |
2-(8-乙基-3-(甲氧基甲氧基)萘-1-基)-4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷 |
2-(8-Ethyl-3-(methoxymethoxy)naphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxabor
|
RH131509 |
Pyr6 |
Pyr6 is a selective inhibitor of TRPC3 with IC50 of 0.49 uM.
|
RH131512 |
PSB-12062(N-(p-Methylphenylsulfonyl)phenoxazine) |
PSB-12062 is a potent and selective P2X4 antagonist with an IC50 of 1.38 μM for
|
RH131513 |
KKL-35 |
KKL-35 is a trans-translation tagging reaction inhibitor with an IC50 of 0.9 µM.
|
RH131514 |
N'-(4-(二乙基氨基)-2-羟基亚苄基)异烟酰肼 |
RSVA405 is a potent, orally active activator of AMPK, with an EC50 of 1 μM. RSVA
|
RH131515 |
N'-[4-(diethylamino)-2-hydroxybenzylidene]isonicotinohydrazide |
N'-[4-(diethylamino)-2-hydroxybenzylidene]isonicotinohydrazide
|
RH131517 |
四甲基姜黄素 |
Tetramethylcurcumin (FLLL31), derived from curcumin, specifically suppresses the
|
RH131518 |
IGS-1.76 |
IGS-1.76 efficiently inhibits the human NCS-1/Ric8a complex. IGS-1.76 shows a si
|
RH131519 |
Anti-inflammatory agent 34 |
Anti-inflammatory agent 34 (Compound IVf) is an orally active anti-inflammatory
|
RH131520 |
Benzamide, 4-chloro-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)- |
Benzamide, 4-chloro-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-
|
RH131521 |
COH-SR4 |
COH-SR4 is an AMPK activator. COH-SR4 shows potent anti-proliferative activities
|
RH131522 |
N-((6-甲基吡啶-2-基)羰基)苯甲酰胺 |
N-((6-Methylpyridin-2-yl)carbamothioyl)benzamide
|
RH131523 |
4-([1,1'-biphenyl]-4-yl)-N-(6-methylpyridin-2-yl)thiazol-2-amine |
4-([1,1'-biphenyl]-4-yl)-N-(6-methylpyridin-2-yl)thiazol-2-amine
|
RH131524 |
5H-Indolo[2,3-b]quinoxaline, 9-methyl- |
5H-Indolo[2,3-b]quinoxaline, 9-methyl-
|
RH131525 |
Propanedinitrile, 2-[(5Z)-5-[[4-(dimethylamino)phenyl]methylene]-4-oxo-2-thiazolidinylidene]- |
Propanedinitrile, 2-[(5Z)-5-[[4-(dimethylamino)phenyl]methylene]-4-oxo-2-thiazol
|
RH131526 |
5-LOX-IN-1 |
5-LOX-IN-1 (compound 2b) is an inhibitor of human 5-Lipoxygenase (5-LOX) with an
|